813
Participants
Start Date
June 29, 2017
Primary Completion Date
June 7, 2018
Study Completion Date
June 7, 2018
IDP-123 Lotion
Tazarotene 0.045% Lotion
IDP-123 Vehicle Lotion
Vehicle Lotion
Valeant site 20, New York
Valeant Site 36, New York
Valeant Site 01, San Diego
Valeant Site 45, Norfolk
Valeant Site 09, High Point
Valeant Site 26, Newnan
Valeant Site 33, Ormond Beach
Valeant Site 13, Sanford
Valeant Site 27, Pembroke Pines
Valeant Site 40, North Miami Beach
Valeant Site 03, West Palm Beach
Valeant Site 35, Boca Raton
valeant Site 14, Nashville
Valeant Site 34, Knoxville
Valeant Site 22, Louisville
Valeant Site 11, Dublin
Valeant Site 32, Cincinnati
Valeant Site 17, South Bend
Valeant Site 23, New Albany
Valeant Site 16, Warren
Valeant Site 38, Detroit
Valeant Site 06, Arlington Heights
Valeant Site 31, Overland Park
Valeant Site 08, Metairie
Valeant Site 24, Hot Springs
Valeant Site 18, Plano
Valeant Site 05, Katy
Valeant Site 43, Webster
Valeant Site 25, San Antonio
Valeant Site 12, Austin
Valeant Site 37, Wheat Ridge
Valeant Site 30, Boise
Valeant Site 41, Salt Lake City
Valeant Site 19, Phoenix
Valeant Site 21, Phoenix
Valeant Site 02, Manhattan Beach
Valeant Site 04, La Mesa
Valeant Site 42, Murrieta
Valeant Site 39, Sacramento
valeant Site 07, Gresham
Valeant Site 44, Spokane
Valeant Site 15, Johnston
Valeant Site 29, Peterborough
Valeant Site 28, Waterloo
Valeant Site 10, Laval
Bausch Health Americas, Inc.
INDUSTRY